Literature DB >> 16227612

Impaired immune responses and prolonged allograft survival in Sly1 mutant mice.

Sandra Beer1, Tanja Scheikl, Bernhard Reis, Norbert Hüser, Klaus Pfeffer, Bernhard Holzmann.   

Abstract

Adaptive immunity is crucial for protective host defense and the development of immunological disorders. SLY1 was recently identified as an X-chromosomal SH3 protein that is serine phosphorylated (Ser27) upon B-and T-cell receptor engagement. Here, we demonstrate that SLY1 is localized in the cytoplasm and the nucleus of immunocytes. We generated mice expressing a mutant version of SLY1 lacking Ser27 and a functional nuclear localization signal. The defective SLY1 (SLY1(d)) protein is localized exclusively in the cytoplasm. B- and T-cell proliferation is attenuated and T-cell cytokine production is severely reduced. Sly1(d/d) mice exhibit reduced lymphoid organ sizes, diminished marginal zone B-cell numbers, and severely impaired antibody responses against T-dependent and -independent antigens. Importantly, survival of semi-identical cardiac allografts was substantially prolonged in Sly1(d/d) mice. These results define SLY1 as an essential molecular component for the full activation of adaptive immunity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16227612      PMCID: PMC1265838          DOI: 10.1128/MCB.25.21.9646-9660.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  39 in total

1.  Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28-/- mice.

Authors:  S Maier; C Tertilt; N Chambron; K Gerauer; N Hüser; C D Heidecke; K Pfeffer
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

Review 2.  T-Independent immune response: new aspects of B cell biology.

Authors:  S Fagarasan; T Honjo
Journal:  Science       Date:  2000-10-06       Impact factor: 47.728

3.  Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response.

Authors:  R Guinamard; M Okigaki; J Schlessinger; J V Ravetch
Journal:  Nat Immunol       Date:  2000-07       Impact factor: 25.606

4.  Bacterial CpG-DNA activates dendritic cells in vivo: T helper cell-independent cytotoxic T cell responses to soluble proteins.

Authors:  T Sparwasser; R M Vabulas; B Villmow; G B Lipford; H Wagner
Journal:  Eur J Immunol       Date:  2000-12       Impact factor: 5.532

5.  Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice.

Authors:  M B Alimzhanov; D V Kuprash; M H Kosco-Vilbois; A Luz; R L Turetskaya; A Tarakhovsky; K Rajewsky; S A Nedospasov; K Pfeffer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

Review 6.  Marginal zone B cells.

Authors:  Shiv Pillai; Annaiah Cariappa; Stewart T Moran
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

7.  Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism.

Authors:  H J Cho; K Takabayashi; P M Cheng; M D Nguyen; M Corr; S Tuck; E Raz
Journal:  Nat Biotechnol       Date:  2000-05       Impact factor: 54.908

8.  The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases.

Authors:  D Vetrie; I Vorechovský; P Sideras; J Holland; A Davies; F Flinter; L Hammarström; C Kinnon; R Levinsky; M Bobrow
Journal:  Nature       Date:  1993-01-21       Impact factor: 49.962

9.  Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene.

Authors:  A J Coffey; R A Brooksbank; O Brandau; T Oohashi; G R Howell; J M Bye; A P Cahn; J Durham; P Heath; P Wray; R Pavitt; J Wilkinson; M Leversha; E Huckle; C J Shaw-Smith; A Dunham; S Rhodes; V Schuster; G Porta; L Yin; P Serafini; B Sylla; M Zollo; B Franco; A Bolino; M Seri; A Lanyi; J R Davis; D Webster; A Harris; G Lenoir; G de St Basile; A Jones; B H Behloradsky; H Achatz; J Murken; R Fassler; J Sumegi; G Romeo; M Vaudin; M T Ross; A Meindl; D R Bentley
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

10.  CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity.

Authors:  H S Azzam; A Grinberg; K Lui; H Shen; E W Shores; P E Love
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

View more
  12 in total

1.  Cannabinoid receptor 2 is critical for the homing and retention of marginal zone B lineage cells and for efficient T-independent immune responses.

Authors:  Sreemanti Basu; Avijit Ray; Bonnie N Dittel
Journal:  J Immunol       Date:  2011-11-02       Impact factor: 5.422

2.  SASH3 variants cause a novel form of X-linked combined immunodeficiency with immune dysregulation.

Authors:  Ottavia M Delmonte; Jenna R E Bergerson; Tomoki Kawai; Hye Sun Kuehn; David H McDermott; Irene Cortese; Michael T Zimmermann; A Kerry Dobbs; Marita Bosticardo; Danielle Fink; Shamik Majumdar; Boaz Palterer; Francesca Pala; Nikita R Dsouza; Marie Pouzolles; Naomi Taylor; Katherine R Calvo; Stephen R Daley; Daniel Velez; Anahita Agharahimi; Katherine Myint-Hpu; Lesia K Dropulic; Jonathan J Lyons; Steven M Holland; Alexandra F Freeman; Rajarshi Ghosh; Morgan B Similuk; Julie E Niemela; Jennifer Stoddard; Douglas B Kuhns; Raul Urrutia; Sergio D Rosenzweig; Magdalena A Walkiewicz; Philip M Murphy; Luigi D Notarangelo
Journal:  Blood       Date:  2021-09-23       Impact factor: 25.476

3.  Prognostic significance of downregulated expression of the candidate tumour suppressor gene SASH1 in colon cancer.

Authors:  C Rimkus; M Martini; J Friederichs; R Rosenberg; D Doll; J R Siewert; B Holzmann; K P Janssen
Journal:  Br J Cancer       Date:  2006-10-31       Impact factor: 7.640

4.  Clinical Significance of SASH1 Expression in Glioma.

Authors:  Liu Yang; Haitao Zhang; Qi Yao; Yingying Yan; Ronghua Wu; Mei Liu
Journal:  Dis Markers       Date:  2015-09-06       Impact factor: 3.434

5.  Deficiency of the adaptor protein SLy1 results in a natural killer cell ribosomopathy affecting tumor clearance.

Authors:  Saeed Arefanian; Daniel Schäll; Stephanie Chang; Reza Ghasemi; Ryuji Higashikubo; Alex Zheleznyak; Yizhan Guo; Jinsheng Yu; Hosseinali Asgharian; Wenjun Li; Andrew E Gelman; Daniel Kreisel; Anthony R French; Hani Zaher; Beatrice Plougastel-Douglas; Leonard Maggi; Wayne Yokoyama; Sandra Beer-Hammer; Alexander S Krupnick
Journal:  Oncoimmunology       Date:  2016-09-27       Impact factor: 8.110

6.  Structure of the SLy1 SAM homodimer reveals a new interface for SAM domain self-association.

Authors:  Laura Kukuk; Andrew J Dingley; Joachim Granzin; Luitgard Nagel-Steger; Pallavi Thiagarajan-Rosenkranz; Daniel Ciupka; Karen Hänel; Renu Batra-Safferling; Victor Pacheco; Matthias Stoldt; Klaus Pfeffer; Sandra Beer-Hammer; Dieter Willbold; Bernd W Koenig
Journal:  Sci Rep       Date:  2019-01-10       Impact factor: 4.379

7.  The orphan adapter protein SLY1 as a novel anti-apoptotic protein required for thymocyte development.

Authors:  Bernhard Reis; Klaus Pfeffer; Sandra Beer-Hammer
Journal:  BMC Immunol       Date:  2009-07-15       Impact factor: 3.615

8.  Somatic overgrowth associated with homozygous mutations in both MAN1B1 and SEC23A.

Authors:  Swati Gupta; Somayyeh Fahiminiya; Tracy Wang; Laura Dempsey Nunez; David S Rosenblatt; William T Gibson; Brian Gilfix; John J M Bergeron; Loydie A Jerome-Majewska
Journal:  Cold Spring Harb Mol Case Stud       Date:  2016-05

9.  Comparative Transcriptomic Analysis of Rectal Tissue from Beef Steers Revealed Reduced Host Immunity in Escherichia coli O157:H7 Super-Shedders.

Authors:  Ou Wang; Guanxiang Liang; Tim A McAllister; Graham Plastow; Kim Stanford; Brent Selinger; Le Luo Guan
Journal:  PLoS One       Date:  2016-03-09       Impact factor: 3.240

10.  Comprehensive analysis of DNA methylation and gene expression in orally tolerized T cells.

Authors:  Ayano Toyoda; Toshinori Kozaki; Kazuo Ishii; Momoka Taniishi; Makoto Hattori; Hiroshi Matsuda; Tadashi Yoshida
Journal:  PLoS One       Date:  2020-02-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.